Well Lead Medical Co., Ltd. (603309.SS)
CNY 11.52
(2.31%)
CNY 11.52
(2.31%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 749.55 Million CNY | 16.42% |
| 2022 | 643.85 Million CNY | 19.04% |
| 2021 | 540.87 Million CNY | 56.85% |
| 2020 | 344.82 Million CNY | -17.77% |
| 2019 | 419.34 Million CNY | -11.61% |
| 2018 | 474.41 Million CNY | 328.82% |
| 2017 | 110.63 Million CNY | 1.15% |
| 2016 | 109.37 Million CNY | 6.78% |
| 2015 | 102.43 Million CNY | -34.18% |
| 2014 | 155.61 Million CNY | -9.07% |
| 2013 | 171.14 Million CNY | 7.12% |
| 2012 | 159.77 Million CNY | -7.05% |
| 2011 | 171.89 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 885.34 Million CNY | -8.45% |
| 2024 Q1 | 947.83 Million CNY | 26.45% |
| 2024 Q2 | 967.06 Million CNY | 2.03% |
| 2023 Q1 | 640.59 Million CNY | -0.51% |
| 2023 Q4 | 749.55 Million CNY | 27.18% |
| 2023 FY | 749.55 Million CNY | 16.42% |
| 2023 Q3 | 589.35 Million CNY | 5.49% |
| 2023 Q2 | 558.66 Million CNY | -12.79% |
| 2022 Q1 | 555 Million CNY | 2.61% |
| 2022 FY | 643.85 Million CNY | 19.04% |
| 2022 Q4 | 643.85 Million CNY | 10.79% |
| 2022 Q3 | 581.15 Million CNY | -3.52% |
| 2022 Q2 | 602.38 Million CNY | 8.54% |
| 2021 Q4 | 540.87 Million CNY | 22.32% |
| 2021 Q2 | 414.73 Million CNY | 20.63% |
| 2021 FY | 540.87 Million CNY | 56.85% |
| 2021 Q3 | 442.17 Million CNY | 6.62% |
| 2021 Q1 | 343.8 Million CNY | -0.3% |
| 2020 Q4 | 344.82 Million CNY | -9.27% |
| 2020 Q3 | 380.05 Million CNY | -5.23% |
| 2020 Q2 | 401.02 Million CNY | 0.01% |
| 2020 FY | 344.82 Million CNY | -17.77% |
| 2020 Q1 | 400.98 Million CNY | -4.38% |
| 2019 Q2 | 424.49 Million CNY | -1.76% |
| 2019 Q1 | 432.07 Million CNY | -8.92% |
| 2019 FY | 419.34 Million CNY | -11.61% |
| 2019 Q4 | 419.34 Million CNY | 0.55% |
| 2019 Q3 | 417.06 Million CNY | -1.75% |
| 2018 Q3 | 184.21 Million CNY | 6.83% |
| 2018 Q4 | 474.41 Million CNY | 157.54% |
| 2018 FY | 474.41 Million CNY | 328.82% |
| 2018 Q1 | 96.37 Million CNY | -12.89% |
| 2018 Q2 | 172.43 Million CNY | 78.93% |
| 2017 Q2 | 108.08 Million CNY | 13.99% |
| 2017 FY | 110.63 Million CNY | 1.15% |
| 2017 Q4 | 110.63 Million CNY | -1.09% |
| 2017 Q3 | 111.85 Million CNY | 3.49% |
| 2017 Q1 | 94.81 Million CNY | -13.31% |
| 2016 Q3 | 74.98 Million CNY | -7.93% |
| 2016 FY | 109.37 Million CNY | 6.78% |
| 2016 Q4 | 109.37 Million CNY | 45.86% |
| 2016 Q2 | 81.44 Million CNY | -2.25% |
| 2016 Q1 | 83.32 Million CNY | -18.66% |
| 2015 Q3 | 100.72 Million CNY | 1.14% |
| 2015 FY | 102.43 Million CNY | -34.18% |
| 2015 Q4 | 102.43 Million CNY | 1.7% |
| 2015 Q2 | 99.58 Million CNY | 4.27% |
| 2015 Q1 | 95.51 Million CNY | -38.63% |
| 2014 Q2 | 189.52 Million CNY | 0.0% |
| 2014 Q4 | 155.61 Million CNY | 0.0% |
| 2014 Q1 | - CNY | 0.0% |
| 2014 FY | 155.61 Million CNY | -9.07% |
| 2013 FY | 171.14 Million CNY | 7.12% |
| 2012 FY | 159.77 Million CNY | -7.05% |
| 2011 FY | 171.89 Million CNY | 0.0% |